Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
01/15/2009 | US20090018166 New Pyridine Analogues X 161 |
01/15/2009 | US20090018164 Farnesyl protein transferase inhibitors for treating breast cancer |
01/15/2009 | US20090018163 Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
01/15/2009 | US20090018160 Heterocyclic Compounds with Affinity to Muscarinic Receptors |
01/15/2009 | US20090018153 antiproliferative; cancer, psoriasis; increased bioavailability |
01/15/2009 | US20090018152 Aminophenyl Derivatives as Novel Inhibitors of Histone Deacetylase |
01/15/2009 | US20090018150 5-Ht2b Receptor Antagonists |
01/15/2009 | US20090018145 Compositions and their use as anti-tumor agents |
01/15/2009 | US20090018141 Kinase inhibitors, compositions thereof, and methods of use therewith |
01/15/2009 | US20090018139 Treatment of CRTH2-mediated diseases and conditions |
01/15/2009 | US20090018138 Treatment of CRTH2-mediated diseases and conditions |
01/15/2009 | US20090018133 Novel Adamantane Derivatives |
01/15/2009 | US20090018131 Quinazoline derivatives as p13 kinase inhibitors |
01/15/2009 | US20090018124 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same |
01/15/2009 | US20090018118 Heterocyclic compounds |
01/15/2009 | US20090018112 Compounds and Uses Thereof |
01/15/2009 | US20090018056 Heteroarylcarbamoylbenzene derivatives |
01/15/2009 | US20090017441 Asymmetric cyanine fluorescent dyes |
01/15/2009 | US20090017330 Material for organic electroluminescence device and organic electroluminescence device utilizing the same |
01/15/2009 | US20090017084 skin-friendly formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects, in particular imidacloprid, for controlling parasitic insects on animals |
01/15/2009 | CA2692783A1 Quinazolinone t-type calcium channel antagonists |
01/15/2009 | CA2692671A1 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
01/15/2009 | CA2692611A1 Di(arylamino)aryl compounds |
01/15/2009 | CA2692374A1 Isothiazole and pyrazole derivatives as fungicides |
01/15/2009 | CA2690756A1 Novel compounds as cannabinoid receptor ligands |
01/15/2009 | CA2690349A1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
01/15/2009 | CA2681624A1 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
01/14/2009 | EP2014657A1 Diaminopyrimidines as modulators for an EP2 receptor |
01/14/2009 | EP2014656A2 New heteocyclic h3 antagonists |
01/14/2009 | EP2014287A1 Use of cinnamic acid derivatives as modulators of an EP2 receptor |
01/14/2009 | EP2013198A2 Solid-state form of amg 706 and pharmaceutical compositions thereof |
01/14/2009 | EP2013197A1 Phenethanolamine derivatives as beta2 adrenoreceptor agonists |
01/14/2009 | EP2013183A1 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the beta2 adrenergic receptor |
01/14/2009 | EP2013182A2 Aminoquinolones as gsk-3 inhibitors |
01/14/2009 | EP2013181A1 Pyridyl compounds |
01/14/2009 | EP2013174A2 Diaryl substituted alkanes |
01/14/2009 | EP2013172A1 New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder |
01/14/2009 | EP2013170A1 4-squarylpiperazine derivatives as antiviral agents |
01/14/2009 | EP1898917B1 Aminopyrimidines as kinase modulators |
01/14/2009 | EP1789395B1 Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof |
01/14/2009 | EP1751103B1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
01/14/2009 | EP1663974B1 2-pyridone derivatives as netrophil elastase inhibitors and their use |
01/14/2009 | EP1567518B1 Oxime ester photoinitiators with heteroaromatic groups |
01/14/2009 | EP1560584B1 Fab i inhibitors |
01/14/2009 | EP1532120B1 Phenylpyridazine derivatives as ligands for gaba receptors |
01/14/2009 | EP1478363B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
01/14/2009 | CN101346381A New anti-malaria derivatives of 4-aminoquinoline |
01/14/2009 | CN101346369A Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
01/14/2009 | CN101346368A Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists |
01/14/2009 | CN101346360A Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof |
01/14/2009 | CN101346353A Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
01/14/2009 | CN101346141A Quinoline derivatives useful in the treatment of MGLUR5 receptor-mediated disorders |
01/14/2009 | CN101343267A Preparation method for optical pure Pantoprazole |
01/14/2009 | CN101343266A Preparation method for optical pure rebeprazole |
01/14/2009 | CN101343251A Thrombopoietin mimetics |
01/14/2009 | CN101343250A Thrombopoietin mimetics |
01/14/2009 | CN101342169A Thrombopoietin mimetics |
01/14/2009 | CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors |
01/14/2009 | CN100451015C Preparing method of imatinib |
01/14/2009 | CN100451014C Process for making chiral 1,4-disubstituted piperazines |
01/14/2009 | CN100450483C Stabilized pharmaceutical compositions contg. calcium channel blockers |
01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
01/13/2009 | US7478376 Computer program code size partitioning method for multiple memory multi-processing systems |
01/13/2009 | US7476746 PPAR active compounds |
01/13/2009 | US7476688 Cyclic amidine derivatives |
01/13/2009 | US7476685 Pyridine carboxamide derivatives and their use as pesticides |
01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
01/13/2009 | US7476682 N-substituted piperidine derivatives as serotonin receptor agents |
01/13/2009 | US7476681 anticarcinogenic agent; prostate cancer, benign prostatic hyperplasia, prostatic intraepithelial neoplasia, hirsutism, acne, androgenic alopecia, or polycystic ovary syndrome, prostate, lung, pancreatic, colon, renal cancer, myeloid leukemia |
01/13/2009 | US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
01/13/2009 | US7476675 Quinolinone derivatives and uses thereof |
01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
01/13/2009 | US7476665 Benzodiazepine CGRP receptor antagonists |
01/13/2009 | US7476663 Substituted thiophene carboxamides |
01/13/2009 | CA2392902C Substituted bisindolylmaleimides for the inhibition of cell proliferation |
01/13/2009 | CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
01/13/2009 | CA2346506C Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
01/13/2009 | CA2293372C Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
01/13/2009 | CA2216542C 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity |
01/08/2009 | WO2009006580A1 Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers |
01/08/2009 | WO2009006567A2 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
01/08/2009 | WO2009006389A2 Pyrimidine derivatives useful as raf kinase inhibitors |
01/08/2009 | WO2009006255A1 Particulate (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of its use |
01/08/2009 | WO2009006061A2 Process for preparing 2-amino-5-cyanobenzoic acid derivatives |
01/08/2009 | WO2009005729A1 Gamma secretase modulators |
01/08/2009 | WO2009005674A2 Novel hiv reverse transcriptase inhibitors |
01/08/2009 | WO2009005671A2 Substituted piperazines as cb1 antagonists |
01/08/2009 | WO2009005646A2 Substituted piperazines as cb1 antagonists |
01/08/2009 | WO2009005645A1 Substituted piperazines as cb1 antagonists |
01/08/2009 | WO2009005471A1 Aryl and heteroaryl substituted isoindole derivatives as bace inhibitors |
01/08/2009 | WO2009005470A1 Aryl and heteroaryl substituted isoindole derivatives as bace inhibitors |
01/08/2009 | WO2009005459A1 Phenyl-1,2, 3,4-tetrahydroisoquinolinone derivatives and their use in the treatment of a pain disorder |
01/08/2009 | WO2009005076A1 Amide compound |
01/08/2009 | WO2009005002A1 Quinolone derivative |
01/08/2009 | WO2009004792A1 Sulfonamide compound, and crystal thereof |
01/08/2009 | WO2009004650A1 Novel substituted piperidones as hsp inducers |
01/08/2009 | WO2009004427A2 Benzimidazole derivatives |